Literature DB >> 19029273

Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.

A Hostmann1, A M Jacobi, H Mei, F Hiepe, T Dörner.   

Abstract

Autoreactive B cells and plasma cells appear to be of central importance in the pathogenesis of systemic lupus erythematosus (SLE) characterized by a plethora of autoantibodies. Recent insights into abnormalities of B cell and plasma cell compartments in human SLE have identified a number of cellular disturbances within these compartments that in part correlate with the disease activity. This review discusses these findings and the potential underlying extrinsic and/or intrinsic influences apparently driving general B cell activation in this entity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19029273     DOI: 10.1177/0961203308095138

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  18 in total

1.  Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70.

Authors:  Joanne Shaw; Yui-Hsi Wang; Tomoki Ito; Kazuhiko Arima; Yong-Jun Liu
Journal:  Blood       Date:  2010-02-04       Impact factor: 22.113

2.  Interleukin-6 gene polymorphism in Iranian patients with systemic lupus erythematosus.

Authors:  Esmaeil Moazemi Godarzi; Eskandar Kamali Sarvestani; Elham Aflaki; Zahra Amirghofran
Journal:  Clin Rheumatol       Date:  2010-04-11       Impact factor: 2.980

Review 3.  Innate pathways to B-cell activation and tolerance.

Authors:  Steve P Crampton; Elisaveta Voynova; Silvia Bolland
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

4.  Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms.

Authors:  Abhishek Chandra; Gary P Wormser; Mark S Klempner; Richard P Trevino; Mary K Crow; Norman Latov; Armin Alaedini
Journal:  Brain Behav Immun       Date:  2010-03-18       Impact factor: 7.217

Review 5.  Serpins, immunity and autoimmunity: old molecules, new functions.

Authors:  Mariele Gatto; Luca Iaccarino; Anna Ghirardello; Nicola Bassi; Patrizia Pontisso; Leonardo Punzi; Yehuda Shoenfeld; Andrea Doria
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 6.  B-cell-depletion therapy in SLE--what are the current prospects for its acceptance?

Authors:  Catarina Favas; David A Isenberg
Journal:  Nat Rev Rheumatol       Date:  2009-12       Impact factor: 20.543

Review 7.  IL-21 acts as a promising therapeutic target in systemic lupus erythematosus by regulating plasma cell differentiation.

Authors:  Xiao-Mei Deng; Shang-Xue Yan; Wei Wei
Journal:  Cell Mol Immunol       Date:  2014-08-04       Impact factor: 11.530

8.  Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans.

Authors:  Lingyun Sun; Kentaro Akiyama; Huayong Zhang; Takayoshi Yamaza; Yayi Hou; Shengnan Zhao; Ting Xu; Anh Le; Songtao Shi
Journal:  Stem Cells       Date:  2009-06       Impact factor: 6.277

9.  Pharmacokinetics and safety of single doses of tabalumab in subjects with rheumatoid arthritis or systemic lupus erythematosus.

Authors:  Jennifer Witcher; Roy Fleischmann; Vishala L Chindalore; Ryan J Hansen; Leijun Hu; David Radtke; James Voelker; Elisa Gomez; Juliet McColm
Journal:  Br J Clin Pharmacol       Date:  2016-02-25       Impact factor: 4.335

10.  Prolactin rescues and primes autoreactive B cells directly and indirectly through dendritic cells in B6.Sle3 mice.

Authors:  J Gonzalez; S Saha; E Peeva
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.